Fadraciclib

Fadraciclib · Cyclacel Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fadraciclib, covering 2024-01-25 to 2024-01-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma [Phase 1, Phase 2]

See pricing